Biotechnology

Techseriesinsight > Blog > News > Biotechnology

April 1, 2025
PRNewswire
Biotechnology

Adcendo ApS Announces Changes in Board of Directors and Strengthens Executive Leadership Team

Adcendo, a biotech company pioneering the development of first- and potential best-in-class antibody-drug conjugates (ADCs) for cancers with a high unmet medical need, today announced two important Board changes...

March 27, 2025
PRNewswire
Biotechnology

Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing

Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in individuals who are blind or losing vision due to various retinal degenerative diseases, today announced that Ashish Patel, PhD,...

March 26, 2025
PRNewswire
Biotechnology

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneering biotechnology company focused on developing innovative immunotherapies, today announced final data from the successful conclusion of its open-label Phase 2a...

March 25, 2025
PRNewswire
Biotechnology

AngeoPro Yeast Protein Wins 2025 World Best Ingredient Innovation Award, Pioneering a New Era of Sustainable Protein

The 2025 World Food Innovation Awards, hosted by FoodBev, took place on March 17, 2025 at the IFE International Food and Beverage Exhibition’s “Trend and Innovation Platform” in London, UK. AngeoPro Yeast...

March 25, 2025
PRNewswire
Biotechnology

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has entered into a letter of intent...

March 24, 2025
PRNewswire
Biotechnology

Tempero Bio Secures $70 Million Series B Financing to Advance TMP-301 into Phase 2 Trials for Substance Use Disorders

Tempero Bio, Inc., a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders, today announced the closing of a $70 million Series B financing. The financing was led by 8VC...

March 24, 2025
PRNewswire
Biotechnology

Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress

Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment of recurrence of Dupuytren contracture following surgical correction will...

March 21, 2025
PRNewswire
Biotechnology

Nanomi Receives CMO Award for Life Science Leadership in Drug Delivery

Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug Delivery,...

March 21, 2025
PRNewswire
Biotechnology

The Galien Foundation Honors 2025 Modi Prix Galien India Award Recipients

The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, celebrated excellence and innovation in life sciences during the Prix Galien India Forum and second...

March 20, 2025
PRNewswire
Biotechnology

iOnctura commences randomized Phase II study in metastatic uveal melanoma

iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in the randomized Phase II OCULE-01 study investigating lead asset roginolisib...